Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Colorectal Neoplasms × camrelizumab × Clear all

Phase

Phase 2 9 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6 Esophageal Neoplasms 3 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Gastric Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Immune Checkpoint Inhibition 1 ESCC 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Bites and Stings 1

Interventions

Colonoscopy 39 Standard of Care 24 Early Intervention, Educational 22 Methods 21 Blood Specimen Collection 21 Exercise 18 Educational Status 18 Surveys and Questionnaires 12 Patient Navigation 12 Interviews as Topic 12 Counseling 12 Practice Guidelines as Topic 10 Endoscopic Mucosal Resection 10 Drug Therapy 9 Oxaliplatin 8 Preoperative Exercise 7 Irinotecan 7 Fluorouracil 7 Therapeutics 6 Surgical Procedures, Operative 6 Resistance Training 6 Occult Blood 6 Narrow Band Imaging 6 Mass Screening 6 Lidocaine 6 Decision Support Techniques 6 Control Groups 6 Bevacizumab 6 regorafenib 5 Referral and Consultation 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05202314 2023-02-21

NACSOC-02

Beijing Chao Yang Hospital

Phase NA Recruiting

Gastrointestinal

Bites and Stings, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡